Treatment with Statins, RAAS Inhibitors and Platelet Inhibitors After CABG is Essential, While the Use of Beta-blockers is Questionable: Swedish Study
In a recent study published in the European Heart Journal, Erik Björklund…
TWILIGHT Trial: Single Anti-Platelet Therapy (SAPT) Using Ticagrelor Reduces Bleeding Risk And Preserves Ischemia Prevention Post-PCI
A randomized, double-blinded, placebo-controlled trial which enrolled 7119 high risk patients with…
Positive Correlation Found Between Combined Life-time Exposure of Decreased LDL-C and Low Systolic BP in Lowering the Risk of Cardiovascular Disease
A recent study by Brian A. Ference et al. based on a…
HOPE 4: A Comprehensive Community-based Program Surpassing the Barriers in Improving BP Control and Associated Cardiovascular Disease Risk in 2 Middle Income Countries
Significant improvement in blood pressure control and related cardiovascular disease (CVD) risk…
ADRIFT Trial: Low-Dose Rivaroxaban is Superior to Dual Antiplatelet Therapy for Controlling Thrombin Generation after Left Atrial Appendage Closure in Atrial Fibrillation Patients
According to the results of Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban…
PolyIran Trial: Polypill Prevents Cardiovascular Events
A four-component polypill, including aspirin, atorvastatin, hydrochlorothiazide, and enalapril or valsartan, effectively…
Population Based Cohort Study: With or Without AFib, CHA₂DS₂-VASc Score is a Sensitive Predictor and Stratifies the Risk of MACCE
Giulia Renda et al. recently published in the European Journal of Preventive…
11,000 Patient Study Demonstrates That Higher 24 hour and Nighttime Blood Pressure Readings Associated With Increased Risk of Cardiac Events
In an original investigation done by Dr.Wen-Yi Yang and his team, the…
Vascular Risk Factors Tied to Unhealthy Brains, Study from UK Biobank Suggests
Vascular risk factors such as smoking, hypertension, and diabetes were associated with…
IMPROVE-IT Trial: Intensive Lipid-Lowering Cuts CVD Risk in the Elderly
Among patients hospitalized for an acute coronary syndrome (ACS), adding ezetimibe to…
Meta-analysis Shows Vitamin D Supplementation Does Not Improve Cardiovascular Outcomes
In the largest updated meta-analysis study conducted to understand the inverse association…
Latest Cross-Sectional Study Links Dietary Pattern Specific Protein Biomarkers to Development of Cardiovascular Disease
According to a nationwide cross-sectional study, protein biomarkers along with specific dietary…
Cohort Study with 27 Years of Follow Up Shows Oral Infections in Children Is Associated with Sub-clinical Atherosclerosis
A study led by Dr. Pirkko Pussinen demonstrated that clinical signs of…
Nationwide Study Shows Pharmacy Closure Associated with Significant Decrease in Adherence to Cardiovascular Medications
According to a new national study led by Dr. Dima M. Qato…
STOPDAPT-2 Explores Safety and Efficacy of 1-month DAPT Followed by Clopidogrel Monotherapy vs Standard 12-month DAPT After Drug-Eluting Stent Implantation
The results of the STOP-DAPT 2 randomized controlled trial were presented by…
Study Depicts Strong Associations Between Social Factors and Mortality Risk Following Coronary Artery Bypass Grafting
According to an observational study posted in the Journal of American Heart…
Anti-Inflammatory Therapy May Not Prevent Atherosclerotic Events
A randomized double-blinded trial called Cardiovascular Inflammation Reduction Trial (CIRT) recently published…
Coronary CTA Provides an Unrivaled Opportunity for More Detailed Analysis in Selected Patients, According to a Study
According to a recent publication in the Journal of the American College…
AVERT: Apixaban for the Prevention of Venous Thromboembolism in High-Risk Ambulatory Cancer Patients
A study by Marc Carrier and his colleagues published in the New…
Statin vs Healthy Adherer Effect On Mortality in ASCVD
In a vigorous retrospective cohort study published in JAMA, Fatima Rodriguez et…